Clinical Trials Covid-19 RSS Feed
Research teams are testing the effectiveness of Artemisia annua against Covid-19, mainly in the United States, but also in Europe and South Africa. Several Chinese studies had shown in 2003 that this plant, traditionally used against malaria, had strong antiviral activity against SARS-Cov-2.
08 Sep2021
0
2175
Artemisia plant extract prevents SARS-CoV-2 replication in vitro The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), was originally detected in Wuhan,..
23 Aug2021
0
2413
A group of researchers in Biochemistry from several universities in Nigeria have just published a study which demonstrates significant activity of Artemisia annua against the severe acute respiratory syndrome coronavirus (SARS-CoV) and the ..
21 Jul2021
0
2273
Denmark, Germany and Hong Kong.Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditionsA team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that se..
18 Jul2021
0
1904
University of Kentucky, USA “Researchers at the Faculty of Medicine launched a clinical trial to verify the plant's effectiveness against COVID-19. A 2005 Chinese study showed that Artemisia annua had strong antiviral activity against SRAS..
18 Jul2021
0
2028
National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico Launch of a large clinical trial in 360 Covid-19 patients with comorbidities (diabetes, obesity, hypertension, etc.) in September 2020. The aim of the clinical tr..
16 Jul2021
0
1900
Artemisia annua effective against SARS-Cov-2
A global coalition of researchers has found that extracts from Artemisia annua can inhibit the replication of SARS-CoV-2 in a laboratory. Publishing in Scientific Reports they report on three dif..
04 May2021
0
2636
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 20..
01 Mar2021
0
1881
India Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.Artemisia research for COVID-19 suggests its ability to inhibit and prevent virus replication. Lung diseases like COVID cause respirato..
07 Oct2020
0
2037
October 7, 2020 - Medical professionals remain cautious, but German media reports that scientists in their country have evidence to suggest that sweet wormwood is effective in treating COVID-19. Known as Slatki Pelin in Croatia, the plant i..
10 Jul2020
0
1963
STATUS OF CLINICAL TRIALS
South AfricaNorthwestern University, South Africa"We are raising funds to scientifically investigate the potential to develop Mugwort into an effective treatment of COVID 19. All funds will be administered by North..
24 Jun2020
0
2732
STATUS OF CLINICAL TRIALSEurope Max Planck Institute and Free University of Berlin (Germany) and University of Copenhagen (Denmark)Effective and affordable treatments are needed for COVID-19 patients. We report the in vitro efficacy of Arte..
Showing 1 to 11 of 11 (1 Pages)
New
Top
-30 %
Very concentrated mother tincture, for oral use. The mother tincture is prepared from the dried annual mugwort plant which comes from a small bio-dyna..
24.00€ 34.50€
Top
Sold out
Very concentrated mother tincture, for oral use. The mother tincture is prepared from the dried annual mugwort plant which comes from a small bio-dyna..
16.00€
Top
Sold out
LOTION SERUM: 100% natural origin, organic extra virgin olive oil, organic sweet almond oil, organic argan vegetable oil, organic jojoba vegetable oil..
66.00€